A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Burger, MD
Day One Biopharmaceuticals, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Comprehensive Cancer Center
Phoenix, Arizona, United States
Felipe Batalini, MDRecruiting - Uc Irvine Health-Chao Family Comprehensive Cancer Center
Orange, California, United States
Ritesh ParajuliRecruiting - Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
Laura Huppert, MDRecruiting - Ucla David Geffen School of Medicine, Division of Hematology/oncology
Santa Monica, California, United States
Nicholas McAndrew, MDRecruiting - Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
Pooja Advani, MDRecruiting - Florida Cancer Specialists
Sarasota, Florida, United States
Judy WangRecruiting - Moffitt Cancer Center
Tampa, Florida, United States
Hyo Han, MDRecruiting - Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
Recruiting - Northwestern University
Chicago, Illinois, United States
Patricia Robinson, MDRecruiting - Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Gerburg Wulf, MDRecruiting - Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Recruiting - Henry Ford Health Hospital
Detroit, Michigan, United States
Recruiting - Mayo Clinic - Rochester
Rochester, Minnesota, United States
Roberto Leon-Ferre, MDRecruiting - Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
Liawaty Ho, MDRecruiting - Ichan School of Medicine at Mount Sinai
New York, New York, United States
Amy TierstenRecruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - New York University Langone Health
New York, New York, United States
Recruiting - Stephenson Cancer Center Oklahoma University Health
Oklahoma City, Oklahoma, United States
Debra Richardson, MDRecruiting - Avera Cancer Institute
Sioux Falls, South Dakota, United States
David C. Starks, MDRecruiting - Sarah Cannon Research Institute (scri)
Nashville, Tennessee, United States
Recruiting - Texas Oncology, P.A.
Dallas, Texas, United States
Joyce O'Shaughnessy, MDRecruiting - Md Anderson
Houston, Texas, United States
Funda Meric-BernstamRecruiting - Huntsman Cancer Institute
Salt Lake City, Utah, United States
Kristen Kelley, MDRecruiting - Next Oncology Virginia
Fairfax, Virginia, United States
Recruiting - Fred Hutchinson Cancer Center
Seattle, Washington, United States
Recruiting - Summit Cancer Centers
Spokane, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Aug 2022
- Primary completion
- 28 Feb 2027
- Completion
- 31 Dec 2027
- Last update posted
- 29 Jun 2026
- Registered enrollment
- 360
- Registry id
- NCT05377996
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.